BBY Research Reports
Perth, Mar 30, 2015 AEST (ABN Newswire) - PhytoTech Medical Limited (
ASX:PYL) (the "Company") advises that BBY Limited ("BBY") initiated research on the Company on 19 March 2015 and has issued an updated research report dated 25 March 2015 in response to the Company's proposed merger with MMJ Bioscience Inc. This research was not commissioned by the Company, however the Company does retain BBY on a corporate advisory basis.
Copies of BBY's research reports are available at:
http://phytotechmed.com/research-report
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
